India's drug regulator has issued a warning that cuts to the heart of a quiet crisis: millions of people reaching for painkillers and antibiotics without medical guidance are unknowingly eroding their kidneys over time. The Central Drugs Standard Control Organisation's advisory arrives against a backdrop of sobering data — chronic kidney disease already touches more than one in eight Indians — and asks a society long accustomed to self-treatment to reckon with the slow cost of that habit. It is a reminder that the most consequential choices are often the most ordinary ones, made not in hospita
India's drug regulator warns against NSAID misuse amid kidney disease surge
Widespread self-medication with NSAIDs and antibiotics contributes to accelerated kidney function decline and chronic kidney disease complications affecting millions of Indians.
Uncontrolled painkiller use accelerates kidney function decline
Mark
So the regulator is saying NSAIDs are being overused. How much of India's kidney disease problem is actually caused by these painkillers?
Mimi
That's the thing—the advisory doesn't quantify it. We know 13.24 percent of Indians have chronic kidney disease, but the regulator hasn't said what fraction of that is driven by NSAID misuse versus other causes like diabetes or high blood pressure.
Luke
Right. And that 13.24 percent figure itself comes with a caveat in the source—the estimates vary widely across regions and studies. So we're working with a pooled number that masks real uncertainty.
Mark
Then why issue the advisory now? What triggered it?
Mimi
The source doesn't say explicitly. But the timing suggests they've seen enough cases of kidney damage linked to painkiller misuse that they felt compelled to act. The regulator is responding to a pattern they're observing.
Luke
But we don't have the data on that pattern. We don't know if kidney disease cases are rising, or if doctors are just reporting more of them, or if the regulator simply decided it was time to reinforce existing rules.
Mark
What about the people already taking NSAIDs regularly? Are they in danger?
Mimi
According to Mahajan, yes—prolonged use accelerates kidney function decline. The risk is especially high for people who already have kidney disease or risk factors like diabetes.
Luke
That's true, but it's also worth noting that NSAIDs are effective medicines when used properly. The advisory isn't saying don't take them; it's saying take them under medical supervision, at the right dose, for the right duration.
Mark
So the real problem is self-medication.
Mimi
Exactly. People buying painkillers at chemists without prescriptions, taking them longer than they should, sharing them with family. That's where the damage happens.
Luke
And the advisory assumes that telling people this will change their behavior. But the source doesn't address whether awareness campaigns actually work in India, or what would need to change to reduce self-medication.
Mark
What happens next?
Mimi
Doctors are supposed to prescribe lower doses for shorter periods. But enforcement and behavior change are different things.
El Pulso
- India's drug regulator has formally warned that unsupervised, repeated use of common painkillers and antibiotics is accelerating kidney disease across a population where chronic kidney damage already affects roughly 13 percent of people.
- The tension is cultural as much as medical — self-medication is deeply entrenched, with millions buying NSAIDs and antibiotics freely at chemists, sharing them within families, and continuing courses long past medical necessity.
- A leading nephrologist at AIIMS has explained the mechanism bluntly: NSAIDs interfere with the kidneys' filtering function, and repeated unsupervised use compounds damage that is often invisible until it is severe.
- The regulator is now pressing both patients and doctors to act differently — patients must disclose NSAID use to physicians, and doctors are directed to prescribe the lowest effective dose for the shortest possible duration.
- The advisory's reach remains uncertain; regulatory guidance struggles to reshape behavior when cheap, accessible medicines and the cultural acceptance of self-treatment continue to make caution feel unnecessary.
India's drug regulator has issued a warning that cuts to the heart of a quiet crisis: millions of people reaching for painkillers and antibiotics without medical guidance are unknowingly eroding their kidneys over time. The Central Drugs Standard Control Organisation's advisory arrives against a backdrop of sobering data — chronic kidney disease already touches more than one in eight Indians — and asks a society long accustomed to self-treatment to reckon with the slow cost of that habit. It is a reminder that the most consequential choices are often the most ordinary ones, made not in hospitals but at pharmacy counters, repeated until the damage is done.
India's drug regulator has issued a pointed advisory warning that the country's widespread habit of taking painkillers and antibiotics without medical supervision is fueling a rise in kidney disease. The Central Drugs Standard Control Organisation identified a clear pattern: NSAIDs and antibiotics — medicines that require a prescription under Indian law — are being used repeatedly and for extended periods without any doctor's involvement, with serious consequences for kidney health.
The scale of the concern is significant. A 2025 review found chronic kidney disease affects roughly 13.24 percent of India's population, a burden that varies by region but is unmistakably large. Nephrologist Sandeep Mahajan of AIIMS explained the danger directly: NSAIDs interfere with the kidneys' ability to filter waste from the blood, and uncontrolled, prolonged use accelerates the decline in kidney function. For those already living with diabetes, high blood pressure, or advancing age, the risk is sharper still.
The advisory addresses both patients and prescribers. People with kidney vulnerabilities are urged to inform their doctor before taking NSAIDs at all. Doctors, meanwhile, are directed to prescribe the lowest effective dose for the shortest necessary duration — guidance intended to reshape how these medicines move through the health system, not merely to advise.
What the warning leaves implicit is perhaps its most sobering dimension: self-medication is so embedded in Indian practice — painkillers bought without prescriptions, antibiotics shared among family members, courses extended because the pain persists — that regulatory guidance alone may not be enough. The advisory is an attempt to interrupt a cycle that is quietly damaging millions of kidneys. Whether it succeeds depends on whether awareness can outpace the convenience and cultural familiarity that make self-treatment feel harmless.
India's drug regulator has sounded a fresh alarm about how people are taking painkillers and antibiotics without a doctor's guidance, warning that the habit is driving a surge in kidney disease across the country. The Central Drugs Standard Control Organisation issued the advisory after recognizing a pattern: NSAIDs—the common over-the-counter painkillers millions reach for without thinking—and antibiotics are being used repeatedly and for extended periods without any medical supervision, putting kidneys at serious risk.
The regulator's position is straightforward. These are prescription medicines under Indian law, not casual remedies. They should be taken only when a doctor says they are needed, at the dose the doctor specifies, for the duration the doctor sets. The circular makes clear that self-medication with these drugs carries real consequences. What makes the warning urgent is the scale of the problem it addresses. A 2025 review of community-based studies found that chronic kidney disease affects roughly 13.24 percent of India's population—a substantial burden that varies significantly by region and study methodology, but unmistakably large.
Sandeep Mahajan, a nephrologist at AIIMS, explained the mechanism plainly: uncontrolled and prolonged use of painkillers accelerates the decline in kidney function. The kidneys filter waste from the blood, and NSAIDs interfere with that process. When someone takes these drugs repeatedly without medical oversight, the damage compounds. For people who already have kidney disease or risk factors for it—diabetes, high blood pressure, older age—the danger is sharper still. The regulator has now advised such people to tell their doctor before taking NSAIDs at all.
The advisory also targets prescribers. Doctors are being told to use the minimum effective dose of NSAIDs and to limit how long patients take them. Extra caution is required for anyone at risk of kidney injury. This is not a suggestion; it is guidance meant to reshape how these medicines move through the health system. The regulator's concern reflects a reality that has become harder to ignore: self-medication is entrenched in Indian practice. People buy painkillers at chemists without prescriptions. They share antibiotics with family members. They continue taking drugs long after the initial problem has passed, because the pain is still there or because they believe the medicine is helping.
What the advisory does not say, but what the numbers imply, is that this behavior is contributing to a public health crisis. Millions of Indians are unknowingly damaging their kidneys through casual painkiller use. The regulator's warning is an attempt to interrupt that cycle—to make clear that what feels like a harmless choice at the pharmacy counter can have serious consequences years later. Whether the advisory will change behavior remains an open question. Awareness campaigns and regulatory guidance have limits when the underlying incentives—cheap, accessible medicines and the cultural acceptance of self-treatment—remain unchanged.
Citas Notables
Unregulated and prolonged use of painkillers can accelerate the decline in kidney function. All prescription medicines should be taken under the supervision of a qualified physician, with the prescribed dose and duration strictly followed.— Prof Sandeep Mahajan, nephrologist at AIIMS
Quieres la nota completa?
Lee el original en The Times of India ↗